Case Report
Multiple Myeloma After Treatment of Essential Thrombocythemia
Abstract
ABSTRACT:An 83-year-old black woman with previously diagnosed essential thrombocythemia was treated with thiotepa to control the excessive number of platelets. Approximately 10 years later, multiple myeloma developed. This appears to be the first case of multiple myeloma occurring after alkylating agent therapy for essential thrombocythemia. Although the mechanism of the development of multiple myeloma has yet to be defined, continuing progress in cell biology may prove a strong association between multiple myeloma and other hematologic malignancies.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
